Mibefradil is a potent inhibitor of both CYP3A and P-glycoprotein (P-gp)
- 1 February 1999
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 65 (2) , 124
- https://doi.org/10.1016/s0009-9236(99)80029-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: